The goal of this collaboration is to perform an exploratory analysis of relevant blood-based biomarkers that could inform future analysis of disease relevant biomarkers in Parkinson’s disease and Parkinson’s disease with GBA1 variants.
|Effective start/end date||8/22/22 → 8/21/23|
- Vanqua Bio, Inc. (VB AGMT 8/22/22)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.